![](https://flagship-pioneering.transforms.svdcdn.com/production/newcos/Jason-G-Ampersand.jpg?w=300&h=300&auto=compress%2Cformat&fit=crop&crop=focalpoint&fp-x=0.7916&fp-y=0.3044&dm=1704901403&s=4d09d3c4be6dcb7b93cf612d525101c8)
Human Health
Filter by Type:
![](https://flagship-pioneering.transforms.svdcdn.com/production/newcos/Jason-G-Ampersand.jpg?w=300&h=300&auto=compress%2Cformat&fit=crop&crop=focalpoint&fp-x=0.7916&fp-y=0.3044&dm=1704901403&s=4d09d3c4be6dcb7b93cf612d525101c8)
![](https://flagship-pioneering.transforms.svdcdn.com/production/newcos/Eric-S-Seres.jpg?w=300&h=300&auto=compress%2Cformat&fit=crop&crop=focalpoint&fp-x=0.5138&fp-y=0.2975&dm=1704901338&s=3cf19f68144a31521cafc941d6500378)
2024 CEO Chat: Eric Shaff, Seres Therapeutics
![](https://flagship-pioneering.transforms.svdcdn.com/production/newcos/Jason-P-Empress.jpg?w=300&h=300&auto=compress%2Cformat&fit=crop&crop=focalpoint&fp-x=0.5614&fp-y=0.3677&dm=1704901252&s=40552a4d0e3f3eeb2ca1f05e9da8b58e)
2024 CEO Chat: Jason Park, Empress Therapeutics
![](https://flagship-pioneering.transforms.svdcdn.com/production/newcos/Chris-Vesalius.jpg?w=300&h=300&auto=compress%2Cformat&fit=crop&crop=focalpoint&fp-x=0.7041&fp-y=0.4091&dm=1704901161&s=a45bced8c9263723bbe43881f7cc806d)
2024 CEO Chat: Christopher Austin, Vesalius
![](https://flagship-pioneering.transforms.svdcdn.com/production/newcos/Still-for-Paul-and-Charlotte-Disucssion.jpg?w=300&h=300&auto=compress%2Cformat&fit=crop&crop=focalpoint&fp-x=0.7957&fp-y=0.5057&dm=1704905144&s=00003bd4de52d40e0534e666893fcc87)
Pioneering Partnerships to Drive Scientific Discovery and Patient Impact
Essay
![](https://flagship-pioneering.transforms.svdcdn.com/production/Lovisa-Essay-Thumbnail.png?w=300&h=300&auto=compress%2Cformat&fit=crop&crop=focalpoint&fp-x=0.5215&fp-y=0.6664&dm=1704893019&s=d234ca0b21ec80afc262beba7617ae40)
Guiding AI Toward Its Potential in Biology
![](https://flagship-pioneering.transforms.svdcdn.com/production/newcos/Adrian-Foghorn.jpg?w=300&h=300&auto=compress%2Cformat&fit=crop&crop=focalpoint&fp-x=0.6546&fp-y=0.2657&dm=1704898130&s=998d8dfce87967fa4d07cb0e2eefb529)
2024 CEO Chat: Adrian Gottschalk, Foghorn Therapeutics
![](https://flagship-pioneering.transforms.svdcdn.com/production/newcos/20240108_Flagship_SF-63.jpg?w=300&h=300&auto=compress%2Cformat&fit=crop&crop=focalpoint&fp-x=0.6545&fp-y=0.3162&dm=1705003666&s=af62ee68fc76cfc3b79d3b1282bcc755)